TY  - BOOK
AU  - Urtal, Gen-Ghis Ramil O.
AU  - Pangaliban, Charlene
AU  - Pilapil, Tresni Ann
AU  - Prejoles, Michaela
AU  - Raymundo, Rouen Lloyd
AU  - Reyes, Jan Henri
AU  - Serna, Joan Archy
TI  - Factors affecting vaccine hesitancy toward COVID-19 vaccination among non-medical frontliners
AV  - M CFM 2023 0008 
PY  - 2023///
CY  - Fairview, Quezon City
PB  - Department of Community and Family Medicine, FEU-NRMF
KW  - vaccine hesitancy
KW  - COVID-19
KW  - SARS-CoV-2
KW  - COVID-19 vaccine
N1  - Include bibliographical references; THDCFM
N2  - Abstract:  This study focused on the factors affecting COVID-19 vaccine hesitancy among non-medical frontliners. Analytical study was employed to examine the relationships between factors such as sociodemographic, income, vaccine status, sources of information, and knowledge on vaccines on vaccine hesitancy. Fisher's Exact Test was used to determine the relationship between perceived effectiveness on COVID-19 vaccine and vaccine hesitancy (p-value = 0.000) which has a significant relationship, while pseudo R2 regression was used to determine the likelihood of being vaccine hesitant. Individuals who think that the COVID-19 vaccine was not effective were at most risk of being vaccine hesitant (POR = 1.67) compared to those who think that it is effective ('baseline', POR = 1.00). Other factors presented in the study such as age, sex, religion, education, occupation, vaccination status, booster shot, preferred vaccine, source of information, social media platform used, safety and knowledge about the vaccine showed no significance. Considering all the factors with no significance evaluated, the most at risk was the middle income respondents (POR = 1.06) and the least effective was those who preferred Johnson and Johnson as their preferred vaccine (POR = 0.89). In conclusion, vaccine hesitancy was not prevalent among non-medical frontliners. This could be attributed to the result of the government's efforts to combat the COVID-19 virus and promote vaccination against it. The time interval when the research was conducted and the peak of mass vaccination efforts must also be considered
ER  -